Yes, here’s the March edition already! I will try and update the post each week as it will be a busy month ahead with Brain Awareness Week in Ireland, National MS Education and Awareness Month is an effort by the Multiple Sclerosis Foundation (MSF) and the US National Multiple Sclerosis Society’s MS Awareness Week. The big news this week is/has been all about coffee. According to the American Academy of Neurology, drinking coffee may be associated with a lower risk of developing multiple sclerosis (MS). Coffee intake may protect against MS, supporting the idea that the drug may have protective effects for the brain,” said study author Ellen Mowry, MD, MCR, with Johns Hopkins University School of Medicine in Baltimore and a member of the American Academy of Neurology. While…

Time flies, as we’re once again nearing the end of February. It’s been an attention-grabbing month, with several positive news stories about treatment and also, about a rather interesting collaboration between Google and Biogen Idec. First of all though, I wanted to add a link displaying how many clinical trials are ongoing as we speak. So dig in, and feel a little bit happier knowing that each day, a lot of people are seeking and working towards better treatment. Additionally, I added two new categories to the list, news about MS Organisations and Diet also. Highlight! Data Visualization Displays 142 Ongoing MS Clinical Trials MURDOCK study confirms Google partnership Google, Biogen Seek Reasons for Advance of Multiple Sclerosis Google Inc (GOOG) And Biogen Idec Inc Join Hands For Multiple Sclerosis…

The first month of 2015 has come and (almost) gone again. With that, it’s full steam ahead in the field of MS research, clinical trials, business news and interesting, general newsworthy bits and pieces. This month, the highlight was the news about MS and stem cell treatment, providing a decent outlook for those looking for alternative treatment. I’ll keep following this news throughout the year, and in the meantime, check out the Highlight! section where the news was published, with usual news stories further down this web page.

Well, it was a busy December, in more ways than one. I hope you all had a great Christmas and wish you the best for 2015. From the amount of research and clinical news we keep hearing about month after month, I can only be optimistic for the future. A cure will not happen tomorrow, next year or even in five years, but we’re edging closer to more relief. My wish is that all those people with primary and secondary MS will receive better treatment options than they now have.

"Hoping for a cure? Of course. I am realistic though, as it might not happen in my lifetime. Simply being part of the solution, is all I wish for right now. Whichever comes first, the 8,000 people with MS in Ireland, 100,000 in the UK, 400,000 in the US and many other people around the world are looking forward, and simply... hope."

It has been a big and very busy September for researchers, clinical trials and pharmaceutical companies. Early this month, the Joint ACTRIMS/ECTRIMS Meeting took place in Boston. For more, please check the extensive website of the conference.